DaVita Inc V.DVA

Primary Symbol: DVA

Healthcare

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

NYSE:DVA - Post by User

DaVita Inc > Q&A with Delivra’s Investor Relations Team

<< Previous

Bullboard Posts

Next >>

Comment by Voteliberalon Dec 15, 2017 7:21am

60 Views

Post# 27162599

RE:RE:RE:RE:RE:Q&A with Delivra’s Investor Relations Team

No I don't know, I just think they should apply for a licence to distrubute not to grow, I would image there some administartion fees, I see no reason not to apply for one. They should do that then make a NR that they did.

Image result for dosecann